Oral amoxicillin and amoxicillin–clavulanic acid: properties, indications and usage

2019/12/04 by A. Huttner, Angela Huttner, Julia Bielicki +11 · 1 voice · 2 citations
Biochemistry, Genetics and Molecular Biology · Immunology and Microbiology · Medicine · #Antibiotic Resistance in Bacteria #Antibiotic Use and Resistance #Antibiotics Pharmacokinetics and Efficacy

paper · doi:10.1016/j.cmi.2019.11.028

openalex publication_date 2019/12/04 · crossref created 2019/12/04 · crossref issued 2020/07/01 · crossref published 2020/07/01 · crossref published-print 2020/07/01 · openalex created_date 2025/10/10 · crossref deposited 2025/10/22 · crossref indexed 2026/07/24 · openalex updated_date 2026/07/28

Citations

• Community-Acquired Pneumonia Requiring Hospitalization among U.S. Adults
• Coagulase-Negative Staphylococci
• The structure of β-lactamases

Cited by

• Evaluation of subcutaneous amoxicillin/clavulanic acid pharmacokinetics as an alternative to the intravenous route in older patients—the PhASAge Study
• Inferring Amoxicillin-Clavulanate Susceptibility From Ampicillin-Sulbactam Susceptibility Against Common Enterobacterales Species

Discussions

• 2. Clavulanate absorption is highly variable, diurnally & with food; but 125mg seems to do the trick so maybe we don’t need higher doses. Incidentally this paper has more details (including other Am [bsky, 1 points, 1 comments]